Phagos

Suresnes, France · Founded 2021 · Privately Held (backing)

Operator of a biotechnology research company intended to provide customizable drugs to replace antibiotics in animal farming. Phagos is based in Suresnes, France and was founded in 2021. It was valued at $59.9 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $31.9 million across 1 recorded round; the latest was a $1.5 million seed round in Jul 2022.

PMV mark · valuation
$59.9M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$31.9M
Last round
Seed Round
Jul 2022
What is Phagos worth?
$59.9MPrivateMarketView mark · Oct 2026

Valued at $59.9M at its early-stage round, Oct 2025. Nothing has traded since.

Free account
More of Phagos with a free account
  • ·The complete investor list: 26 names
  • ·Watch Phagos: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Phagos funding history

1 rounds
DateRoundRaisedPost-money
Jul 2022Seed Round$1.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Phagos valuation

Phagos was valued at $59.9 million at its early-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Phagos raised?

Phagos has raised $31.9 million in total; 1 of its rounds is on record. The largest on record was a $1.5 million seed round in Jul 2022.

Phagos has filed 2 Form Ds with the SEC since 2022, most recently in Nov 2024 (null sold to 13 investors).

How Phagos's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Phagos, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Phagos

What is Phagos worth?
Phagos is valued at $59.9M as of Oct 2026. Valued at $59.9M at its early-stage round, Oct 2025. Nothing has traded since.
How much has Phagos raised?
Phagos has raised $31.9M in total funding across 1 recorded rounds.
When did Phagos last raise?
Phagos last raised in Jul 2022 (Seed Round), raising $1.5M.